Jonathan W. Chen
Corporate Officer/Principal bij MICROPORT SCIENTIFIC CORPORATION
Profiel
Op dit moment bekleedt Jonathan W. Chen de functie van Chief International Business Officer bij MicroPort Scientific Corp. Hij zit ook in de raad van bestuur van Lombard Medical, Inc. en Promaxo, Inc. In het verleden bekleedde hij de functie van Senior Vice President-Business Development voor Angiotech Pharmaceuticals, Inc. en Investment Banker bij Credit Suisse First Boston Corp. Hij behaalde een bachelorgraad aan de Stanford University.
Actieve functies van Jonathan W. Chen
Bedrijven | Functie | Begin |
---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01-06-2021 |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Director/Board Member | - |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Chairman | 12-05-2023 |
Eerdere bekende functies van Jonathan W. Chen
Bedrijven | Functie | Einde |
---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01-01-2011 |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | 01-05-2005 |
LOMBARD MEDICAL, INC. | Director/Board Member | - |
Opleiding van Jonathan W. Chen
Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
LOMBARD MEDICAL, INC. | Health Technology |
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Credit Suisse First Boston Corp. | Finance |
Promaxo, Inc.
Promaxo, Inc. Medical SpecialtiesHealth Technology Promaxo, Inc. develops MRI and MR technology compatible biopsy and treatment devices. It offers prostate cancer screening, diagnosis, and treatment. The company was founded by Amit Vohra and Michael Bartholomew on January 7, 2016 and is headquartered in Rockville, MD. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |